Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AtriCure (ATRC) Long-Term Debt Issuances (2011 - 2024)

AtriCure (ATRC) reported Long-Term Debt Issuances of $61.2 million for Q1 2024, up 512.1% on a QoQ basis from $10.0 million in Q1 2012.

AtriCure (ATRC) has 3 years of Long-Term Debt Issuances data on file, last reported at $61.2 million in Q1 2024.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to $61.2 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $61.2 million (changed N/A YoY) and the FY2024 annual result came in at $61.2 million, changed N/A from the prior year.
  • Long-Term Debt Issuances climbed to $61.2 million in Q1 2024 per ATRC's latest filing, from $10.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $61.2 million in Q1 2024 and bottomed at $61.2 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 46.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 875.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 5.04 Mn
10 AtriCure 1.39 Bn 1.25 Bn 109.31 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 61.21 Mn
Mar 31, 2024 61.21 Mn
Mar 31, 2012 10.00 Mn
Mar 31, 2012 10.00 Mn
Mar 31, 2011 7.50 Mn
Mar 31, 2011 7.50 Mn